🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Margherita Ambrosini

ORCID: 0000-0003-4131-2409
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial.

272 citations

Daniele Rossini, Filippo Pietrantonio, Aurélie Catteau, Lisa Salvatore, Sara Lonardi +32 more

EGFRAmplification in Metastatic Colorectal Cancer

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab069
N/A
0DataRank · unranked
33 citations

Rona Yaeger, Jaclyn F. Hechtman, Paolo Manca, Giovanni Fucà, Henry Walch +21 more